BioSpace News Archive

Awakn’s Nordic expansion begins with new Awakn Clinics Oslo

GNS today announced two abstracts and two oral poster presentations highlighting insight from the Gemini Digital Twin models in Alzheimer’s Disease and Multiple Myeloma will be included at the Clinical Trials on Alzheimer’s Disease conference (CTAD) in San Francisco and the American Society of Hematology (ASH) in New Orleans.

The global vitamin deficiency treatment market size was valued at US$ 5.86 billion in 2021 and is projected to expand at a CAGR of 6.6% from 2022 to 2030.

The global viscosupplementation market was valued at US$ 3.21 billion in 2021 and it is expected to hit around US$ 5.89 billion by 2030, at a CAGR of 7% over forecast period 2022 to 2030.

The global periodontal therapeutics market size was valued at US$ 0.64 billion in 2021 and expected to reach US$ 1.38 billion by 2030 with a CAGR of 8.9% from 2022 to 2030.

According to the report, the global neurological disorder drugs market size surpassed at US$ 78.73 Bn in 2021 and to reach US$ 125.31 billion by 2030 with a CAGR of 5.3% from 2022 to 2030.

According to Vision Research Reports, the global pyrogen testing market size surpassed at US$ 0.94 billion in 2021 and is expected to grow at a CAGR of 12.5% from 2022 to 2030.

G1 Therapeutics, Inc. today announced that Jack Bailey, G1’s Chief Executive Officer, and other members of the executive team will participate virtually in the Evercore ISI HealthCONx Conference. The fireside chat with G1 will be held at 1:25PM EST on November 30, 2022.

The global geriatric medicine market size was valued at US$ 769.96 billion in 2021 and is expected to grow at a CAGR of 6.8% over forecast period 2022 to 2030.

The global antibacterial drugs market size was valued at US$ 47.29 Bn in 2021 and expected to reach US$ 55.04 billion by 2030 with a CAGR of 1.7% from 2022 to 2030.